淀粉样蛋白阳性个体的生物标志物途径异质性

IF 13 1区医学 Q1 CLINICAL NEUROLOGY

Alzheimer's & Dementia Pub Date : 2024-10-17 DOI:10.1002/alz.14287

Lloyd Prosser, Carole H. Sudre, Neil P. Oxtoby, Alexandra L. Young, Ian B. Malone, Emily N. Manning, Hugh Pemberton, Phoebe Walsh, Frederik Barkhof, Geert Jan Biessels, David M. Cash, Josephine Barnes

引用次数: 0

摘要

在淀粉样蛋白阳性患者中，与疾病相关的生物标志物异质性研究不足。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Biomarker pathway heterogeneity of amyloid-positive individuals

In amyloid-positive individuals, disease-related biomarker heterogeneity is understudied.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Alzheimer's & Dementia 医学-临床神经学

CiteScore

14.50

自引率

5.00%

发文量

299

审稿时长

3 months

期刊介绍： Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.